BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 35868738)

  • 1. Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients.
    Khitri MY; Guedon AF; Georgin-Lavialle S; Terrier B; Saadoun D; Seguier J; le Besnerais M; De Moreuil C; Denis G; Gerfaud-Valentin M; Allain JS; Maria A; Bouillet L; Grobost V; Galland J; Kosmider O; Dumont A; Devaux M; Subran B; Schmidt J; Marianetti-Guingel P; Audia S; Palat S; Roux-Sauvat M; Jachiet V; Hirsch P; Fain O; Mekinian A;
    RMD Open; 2022 Jul; 8(2):. PubMed ID: 35868738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
    Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
    Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
    Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
    Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.
    Vitale A; Caggiano V; Martin-Nares E; Frassi M; Dagna L; Hissaria P; Sfriso P; Hernández-Rodríguez J; Ruiz-Irastorza G; Monti S; Tufan A; Piga M; Giardini HAM; Lopalco G; Viapiana O; De Paulis A; Triggianese P; Vitetta R; de-la-Torre A; Fonollosa A; Caroni F; Sota J; Conticini E; Sbalchiero J; Renieri A; Casamassima G; Wiesik-Szewczyk E; Yildirim D; Hinojosa-Azaola A; Crisafulli F; Franceschini F; Campochiaro C; Tomelleri A; Callisto A; Beecher M; Bindoli S; Baggio C; Gómez-Caverzaschi V; Pelegrín L; Soto-Peleteiro A; Milanesi A; Vasi I; Cauli A; Antonelli IPB; Iannone F; Bixio R; Casa FD; Mormile I; Gurnari C; Fiorenza A; Mejia-Salgado G; Kawakami-Campos PA; Ragab G; Ciccia F; Ruscitti P; Bocchia M; Balistreri A; Tosi GM; Frediani B; Cantarini L; Fabiani C
    Semin Arthritis Rheum; 2024 Jun; 66():152430. PubMed ID: 38554594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. French practical guidelines for the diagnosis and management of relapsing polychondritis.
    Arnaud L; Costedoat-Chalumeau N; Mathian A; Sailler L; Belot A; Dion J; Morel N; Moulis G;
    Rev Med Interne; 2023 Jun; 44(6):282-294. PubMed ID: 37236870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
    Georgin-Lavialle S; Terrier B; Guedon AF; Heiblig M; Comont T; Lazaro E; Lacombe V; Terriou L; Ardois S; Bouaziz JD; Mathian A; Le Guenno G; Aouba A; Outh R; Meyer A; Roux-Sauvat M; Ebbo M; Zhao LP; Bigot A; Jamilloux Y; Guillotin V; Flamarion E; Henneton P; Vial G; Jachiet V; Rossignol J; Vinzio S; Weitten T; Vinit J; Deligny C; Humbert S; Samson M; Magy-Bertrand N; Moulinet T; Bourguiba R; Hanslik T; Bachmeyer C; Sebert M; Kostine M; Bienvenu B; Biscay P; Liozon E; Sailler L; Chasset F; Audemard-Verger A; Duroyon E; Sarrabay G; Borlot F; Dieval C; Cluzeau T; Marianetti P; Lobbes H; Boursier G; Gerfaud-Valentin M; Jeannel J; Servettaz A; Audia S; Larue M; Henriot B; Faucher B; Graveleau J; de Sainte Marie B; Galland J; Bouillet L; Arnaud C; Ades L; Carrat F; Hirsch P; Fenaux P; Fain O; Sujobert P; Kosmider O; Mekinian A; ;
    Br J Dermatol; 2022 Mar; 186(3):564-574. PubMed ID: 34632574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.
    Kunishita Y; Kirino Y; Tsuchida N; Maeda A; Sato Y; Takase-Minegishi K; Yoshimi R; Nakajima H
    Front Immunol; 2022; 13():901063. PubMed ID: 35769485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
    Kouranloo K; Dey M; Almutawa J; Myall N; Nune A
    Rheumatol Int; 2024 Jul; 44(7):1219-1232. PubMed ID: 38129348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome.
    Matsumoto H; Fujita Y; Fukatsu M; Ikezoe T; Yokose K; Asano T; Tsuchida N; Maeda A; Yoshida S; Hashimoto H; Temmoku J; Matsuoka N; Yashiro-Furuya M; Sato S; Murakami M; Sato H; Sakuma C; Kawashima K; Shakespear N; Uchiyama Y; Watanabe H; Kirino Y; Matsumoto N; Migita K
    Front Immunol; 2022; 13():897722. PubMed ID: 35757758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular and orbital manifestations in VEXAS syndrome.
    Abumanhal M; Leibovitch I; Zisapel M; Eviatar T; Edel Y; Ben Cnaan R
    Eye (Lond); 2024 Jun; 38(9):1748-1754. PubMed ID: 38548942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A man in his sixties with chondritis and bone marrow failure.
    Midtvedt Ø; Stray-Pedersen A; Andersson H; Gunnarsson R; Tveten K; Ali MM; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2022 Mar; 142(4):. PubMed ID: 35239266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEXAS syndrome: Clinical manifestations, diagnosis, and treatment.
    Loeza-Uribe MP; Hinojosa-Azaola A; Sánchez-Hernández BE; Crispín JC; Apodaca-Chávez E; Ferrada MA; Martín-Nares E
    Reumatol Clin (Engl Ed); 2024 Jan; 20(1):47-56. PubMed ID: 38160120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Restatement. Relapsing polychondritis].
    Mertz P; Arnaud L
    Rev Prat; 2023 May; 73(5):549-556. PubMed ID: 37309797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity and Autoinflammation: Relapsing Polychondritis and VEXAS Syndrome Challenge.
    Cardoneanu A; Rezus II; Burlui AM; Richter P; Bratoiu I; Mihai IR; Macovei LA; Rezus E
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of relapsing polychondritis associated with myelodysplastic syndrome with erythroid hypoplasia/aplasia.
    Heo SW; Cho KH; Ryu JI; Chung SH; Kim CG; Kim SG; Choe JY
    Korean J Intern Med; 2003 Dec; 18(4):251-4. PubMed ID: 14717237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
    Kunimoto H; Miura A; Maeda A; Tsuchida N; Uchiyama Y; Kunishita Y; Nakajima Y; Takase-Minegishi K; Yoshimi R; Miyazaki T; Hagihara M; Yamazaki E; Kirino Y; Matsumoto N; Nakajima H
    Int J Hematol; 2023 Oct; 118(4):494-502. PubMed ID: 37062784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
    Comont T; Heiblig M; Rivière E; Terriou L; Rossignol J; Bouscary D; Rieu V; Le Guenno G; Mathian A; Aouba A; Vinit J; Dion J; Kosmider O; Terrier B; Georgin-Lavialle S; Fenaux P; Mekinian A;
    Br J Haematol; 2022 Feb; 196(4):969-974. PubMed ID: 34651299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEXAS syndrome: relapsing polychondritis and myelodysplastic syndrome with associated immunoglobulin A vasculitis.
    Pàmies A; Ferràs P; Bellaubí-Pallarés N; Giménez T; Raventós A; Colobran R
    Rheumatology (Oxford); 2022 Mar; 61(3):e69-e71. PubMed ID: 34668539
    [No Abstract]   [Full Text] [Related]  

  • 19. Relapsing polychondritis: Best Practice & Clinical Rheumatology.
    Mertz P; Sparks J; Kobrin D; Ogbonnaya SA; Sevim E; Michet C; Arnaud L; Ferrada M
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101867. PubMed ID: 37839908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission of relapsing polychondritis after successful treatment of myelodysplastic syndrome with azacitidine: a case and review of the literature.
    Erden A; Bilgin E; Kılıç L; Sarı A; Armağan B; Büyükaşık Y; Kalyoncu U
    Drug Metab Pers Ther; 2018 Jun; 33(2):105-108. PubMed ID: 29715182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.